calendar
2,241 catalysts · 6,086 phase readout · 2,238 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
2,241 catalysts · 6,086 phase readout · 2,238 8k filing · 395 earnings · 3 pdufa · 2 approval · 1 adcom
Items: 2.02, 9.01
Items: 1.01, 9.01
Items: 8.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 8.01, 9.01
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL